Cases & Deals

Share

Nanobiotix completes €28 million rights issue

March 2014

Client(s) Nanobiotix SA

Jones Day represented Nanobiotix SA, an oncology focused nanomedicine company, in connection with its €28 million (US$39 million) rights issuance of New Shares.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.